Global Pet CBD Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In November 2022, Sky Wellness, a leading provider of CBD products for both humans and pets, announced the relaunch of its canine-focused CBD wellness line under the D Oh Gee brand. The revamped collection introduces three broad-spectrum, THC-free CBD products, each carefully formulated to support joint health and enhance mobility in dogs. Designed with pet wellness in mind, these innovative solutions reflect Sky Wellness's commitment to providing high-quality, natural alternatives for maintaining canine health.

• In August 2022, Pet Releaf, a leading brand in pet wellness, expanded its product range by launching a new collection of CBD grooming products for dogs. This innovative line includes specially formulated CBD-infused shampoos designed to deliver effective skin and coat relief, helping promote healthier, more comfortable pets.

• In March 2022, Healthy TOKYO, a pioneer in wellness innovation, unveiled its first-ever line of CBD pet products in Japan. This new collection features specially crafted CBD-infused treats and supplements designed to support the health and well-being of both cats and dogs, marking a significant step in expanding natural wellness options for pets in the Japanese market.

In this report, the Global Pet CBD Market has been segmented by Animal Type, Indication, Distribution Channel, and Geography.

Global Pet CBD Market, Segmentation by Animal Type

The Global Pet CBD Market has been segmented by Animal Type into Dogs- Foods/Treats, Vitamins & supplements, Cats- Foods/Treats, Vitamins & supplements, and Others.

Segmentation of the Global Pet CBD Market by Animal Type

The Global Pet CBD Market is categorized by animal type, mainly into dogs, cats, and others, with further subdivisions into foods/treats and vitamins & supplements. Among these, the dog segment leads the market, accounting for approximately 65% of the total share. This dominance is fueled by the rising demand for CBD-infused foods, treats, and supplements, as pet owners increasingly seek natural solutions to manage anxiety, joint pain, and skin conditions in their dogs. CBD treats and edibles have become particularly popular, offering a convenient and enjoyable way for dogs to receive their daily dose. Additionally, CBD vitamins and supplements crafted specifically for dogs are gaining popularity as preventative health products, providing targeted support for issues like arthritis and inflammation.

Growing Importance of the Cat Segment

The cat segment also holds a significant position, contributing around 25% to the overall market. Specialized CBD foods, treats, and supplements formulated for cats' distinct physiological needs are becoming more accessible. Products such as CBD treats for cats are addressing common challenges like anxiety, stress, and digestive problems, meeting growing consumer demand. Similarly, CBD supplements for cats help enhance general wellness and manage conditions like joint discomfort, skin allergies, and loss of appetite. Notably, awareness of CBD's benefits for cats has surged by over 40% among pet owners, prompting the development of more tailored, easy-to-use products that fit seamlessly into daily pet care routines.

Emerging Opportunities in the Others Segment

The others segment, which includes pets like rabbits, birds, and small rodents, represents a smaller but steadily expanding portion of the market, currently estimated at around 10%. Although niche, this category is seeing increasing demand for CBD treats, oils, and specialized supplements designed for the unique metabolic needs of smaller animals. This trend reflects the broader growth of the pet CBD industry, as more pet owners seek natural, plant-based remedies for managing pain, anxiety, and overall health across a wide range of species. As consumer interest intensifies, manufacturers are expected to invest further in developing specialized CBD products for these less traditional pets, continuing to diversify and expand the market.

Global Pet CBD Market, Segmentation by Indication

The Global Pet CBD Market has been segmented by Indication into Joint Pain, Anxiety/Stress, Epilepsy, General Health/Wellness, and Other Indications.

Segmentation of the Global Pet CBD Market by Health Indication

The Global Pet CBD Market is segmented by health indication, with key categories including joint pain, anxiety and stress, epilepsy, general health and wellness, and other medical concerns. Leading this segmentation is the joint pain segment, which commands approximately 35% of the total market share. This dominance is largely driven by the rising prevalence of osteoarthritis and related musculoskeletal disorders, especially in aging dogs. CBD products have become a preferred choice for pet owners seeking to reduce inflammation and pain associated with joint issues, ultimately improving mobility and enhancing overall quality of life. As concerns grow over long-term use of traditional pain medications like NSAIDs, more pet parents are turning to natural, plant-based alternatives such as CBD for long-term joint support.

Anxiety and Stress Management in Pets

The anxiety and stress segment represents about 30% of the global pet CBD market and is one of the fastest-growing categories. Pets—particularly dogs—commonly experience separation anxiety, noise-related stress, or anxiety caused by routine disruptions. To manage these behavioral issues, pet owners are increasingly choosing CBD-infused treats, chews, and oils that help calm their pets without the sedative side effects associated with pharmaceutical options. The rising visibility of CBD’s calming effects and its role in promoting emotional balance has significantly increased demand for natural anxiety-relief solutions—especially in households with pets prone to chronic stress or hyperactivity.

CBD for Epilepsy and Seizure Management

The epilepsy segment, contributing an estimated 15% to the total market, is also gaining momentum. Epilepsy and seizure disorders are among the more common neurological conditions in pets, particularly in certain dog breeds. Research indicates that CBD may help lower the frequency and intensity of seizures, making it a promising alternative or complement to conventional anti-epileptic medications. As both veterinarians and pet owners recognize CBD's potential as a safe and non-addictive aid, interest in CBD for seizure management continues to grow.

General Health and Wellness Support

The general health and wellness segment accounts for approximately 15–18% of the pet CBD market and includes a wide variety of products aimed at enhancing immune health, digestive function, skin and coat condition, and promoting healthy aging. These daily wellness supplements are designed to support the overall vitality of pets and are becoming an integral part of preventative care routines. With pet owners increasingly viewing wellness as a long-term investment, the demand for broad-spectrum CBD health products is steadily climbing across various animal categories.

Global Pet CBD Market, Segmentation by Distribution Channel

The Global Pet CBD Market has been segmented by Distribution Channel into Online Retail Channel, Retail Pharmacies , Veterinary Clinics, and Other.

Distribution Channels in the Global Pet CBD Market

The Global Pet CBD Market is structured around four primary distribution channels: Online Retail, Retail Pharmacies, Veterinary Clinics, and Other Channels. Each segment caters to specific consumer behaviors and plays a distinct role in supporting the market’s expansion.

Online Retail Channel

The Online Retail Channel holds the top position, accounting for an estimated 45–50% of total distribution. This growth is fueled by the convenience of e-commerce, enabling pet owners to purchase CBD oils, treats, capsules, and topicals from the comfort of home. Shoppers benefit from the ability to compare prices, read reviews, and access a broader product selection. Many companies use direct-to-consumer (DTC) strategies, which help them expand globally while maintaining competitive pricing. With over 70% of pet owners opting for online platforms to meet recurring wellness needs, this channel is expected to continue its rapid ascent.

Retail Pharmacies

Retail Pharmacies represent around 20–25% of the pet CBD market share. In regions where CBD is being integrated into mainstream retail, pharmacies are emerging as a trusted point of sale. Consumers often view pharmacies as reliable sources for health and wellness products due to their regulatory oversight, product quality assurance, and in-store professional guidance. The increasing availability of CBD pet products in both national chains and independent drugstores is helping solidify this channel’s importance in the overall distribution network.

Veterinary Clinics

Veterinary Clinics contribute roughly 15–18% of the market and are gaining ground as more vets endorse CBD-based treatments. Pet parents are turning to veterinarians for professional advice and clinically backed CBD products to help manage anxiety, arthritis, chronic pain, and seizures. Many clinics now stock CBD items in-house, adding credibility and reassurance for pet owners seeking effective and safe treatment alternatives. As research supporting CBD efficacy grows, so too will this channel's share of the market.

Other Channels

The Other Channels category, comprising approximately 10–12% of total distribution, includes pet specialty stores, natural health food retailers, and online pet marketplaces. These niche outlets typically offer premium, curated CBD selections designed to meet specific consumer preferences such as organic ingredients or locally sourced formulas. As demand for natural and holistic pet health solutions increases, these alternative distribution points are expected to gain relevance and expand their footprint in the market.

Global Pet CBD Market, Segmentation by Geography

In this report, the Global Pet CBD Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Pet CBD Market Share (%), by Geographical Region, 2024

North America

North America holds the largest share of the global pet CBD market, accounting for approximately 45–50% of total market revenue. This dominance is driven by high rates of pet ownership—over 67% of households in the United States own at least one pet—and increasing consumer preference for natural wellness solutions. The U.S. leads the region in CBD product adoption, supported by favorable regulations in many states and a broad presence of established CBD brands. As pet owners increasingly seek alternatives for managing anxiety, pain, and chronic conditions, and with robust e-commerce platforms facilitating access, North America is expected to maintain its leadership in the pet CBD space.

Europe

Europe represents the second-largest regional market, contributing around 20–25% of global pet CBD sales. Although growth is somewhat slower than in North America, the region is rapidly evolving, with countries like the United Kingdom, Germany, and France at the forefront of CBD adoption. Rising awareness of CBD's benefits and increased demand for natural pet supplements are fueling expansion. As regulatory frameworks across the EU become more clearly defined, the European pet CBD market is expected to grow steadily, particularly in Western Europe where wellness trends are increasingly influencing pet care decisions.

Asia Pacific

Asia Pacific is an emerging market in the global pet CBD landscape, currently accounting for approximately 10–12% of market share. Countries like Japan, China, and South Korea are experiencing rising pet ownership, increased disposable incomes, and shifting attitudes toward holistic pet care. While the region still faces regulatory hurdles, consumer interest in alternative therapies for pets is gaining momentum. Growth is expected to accelerate as laws surrounding cannabis-derived products are gradually relaxed, and as domestic brands and online retail platforms begin to enter the market more aggressively.

Middle East & Africa

The pet CBD market in the Middle East and Africa remains relatively nascent, representing less than 5% of global share. However, there is growing interest—particularly among affluent pet owners in urban centers and expatriate communities—in natural health solutions for pets. Countries such as the UAE and South Africa show early signs of potential, especially as conversations around regulatory reform begin to emerge. As legal environments evolve and awareness increases, this region could become a notable contributor to future market growth.

Latin America

Latin America is a developing market for pet CBD, contributing an estimated 8–10% to the global total. Countries like Brazil and Mexico lead the region in terms of pet ownership and rising interest in pet wellness products. While regulatory uncertainty remains a challenge, growing demand for natural remedies and increased research into CBD’s benefits are encouraging signs. As more progressive cannabis laws are adopted—particularly in countries with forward-looking health policies—the Latin American pet CBD market is projected to expand significantly over the coming years.

This report provides an in depth analysis of various factors that impact the dynamics of Global Pet CBD Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Increasing Pet Humanization
• Rising Pet Health Awareness

• Growing Demand for Natural Remedies- The growing demand for natural remedies is emerging as a key driver of the Global Pet CBD Market, aligning with a broader shift toward holistic health and wellness solutions among consumers. More pet owners are actively seeking plant-based alternatives to traditional pharmaceuticals, particularly for managing chronic conditions such as anxiety, arthritis, pain, and inflammation in animals.

  As the trend of pet humanization accelerates—where pets are viewed as family members—owners are increasingly prioritizing their pets’ health and safety by turning to gentler, natural options. CBD, a non-psychoactive compound derived from hemp, has gained widespread attention for its therapeutic potential without the harsh side effects associated with some conventional medications.This shift toward natural wellness is further fueled by concerns over the long-term use of pharmaceutical drugs in pets, which can lead to issues like liver damage, digestive disorders, and behavioral changes. In contrast, CBD-infused products are perceived to offer safer, more sustainable relief. Pet owners increasingly report positive outcomes using CBD to support their pets’ emotional and physical health, including relief from seizures, joint discomfort, and stress-related behaviors.

  The market is also benefitting from the growing availability of CBD pet products, including oils, edibles, treats, and topicals, which make it easy for pet owners to integrate CBD into their animals’ daily wellness routines. This accessibility, combined with rising consumer awareness, word-of-mouth testimonials, and an expanding base of research supporting CBD’s efficacy, is driving market confidence and adoption. As consumer priorities shift toward clean-label, non-toxic, and evidence-backed pet health solutions, the global pet CBD market is projected to experience sustained growth. With more pet owners seeking natural alternatives to traditional treatments, CBD is positioned as a core component of the future of holistic pet care.

Restraints

• Regulatory Uncertainty
• Lack of Standardized Dosage and Quality Control

• Skepticism Among Veterinarians- Skepticism within the veterinary community remains one of the most significant barriers to the widespread adoption of CBD products in pet care, posing a restraint on the growth of the Global Pet CBD Market. Although CBD has demonstrated potential in managing conditions such as anxiety, chronic pain, arthritis, and seizures in animals, many veterinarians remain hesitant to recommend it due to a lack of conclusive scientific research and clinical trials specifically targeting pets.

  A primary concern among veterinary professionals is the uncertainty surrounding appropriate dosing, long-term safety, and possible interactions between CBD and other medications. In many regions, regulatory guidelines are either unclear or inconsistent, making it difficult for veterinarians to prescribe or recommend CBD products with confidence. This regulatory ambiguity contributes to professional caution, especially where CBD is not formally recognized as a veterinary therapeutic substance.Compounding the issue is the lack of product standardization in the pet CBD market. Unlike pharmaceuticals, many CBD formulations are not subject to rigorous quality testing, resulting in inconsistencies in potency, ingredient transparency, and labeling accuracy. Veterinarians are understandably wary of endorsing products that may vary significantly in composition, particularly when patient safety is at stake.

  Ethical considerations also play a role. Some veterinarians are reluctant to recommend CBD treatments that have not received approval from governing veterinary bodies or undergone extensive peer-reviewed study. This professional responsibility to "do no harm" can discourage even open-minded practitioners from exploring CBD-based therapies, especially in the absence of clear regulatory backing.While a growing number of progressive veterinarians are starting to explore the integration of CBD into treatment protocols, the broader veterinary community continues to approach with caution. Overcoming this challenge will require robust, peer-reviewed research, the development of standardized dosing guidelines, and clear regulatory frameworks that assure both safety and product integrity.Educating veterinary professionals through continuing education programs and transparent clinical data will be key to building trust. Until these concerns are systematically addressed, veterinary skepticism will remain a critical hurdle limiting the full potential of CBD adoption in pet healthcare.

Opportunities

• Increasing Product Innovation
• Expansion into Emerging Markets

• Collaboration with Veterinarians and Pet Care Professionals- Collaboration with veterinarians and pet care professionals is a key growth driver for the Global Pet CBD Market, offering a path to broader acceptance and credibility within mainstream pet wellness. As clinical research continues to validate the therapeutic benefits of CBD for pets, strategic partnerships with veterinarians and animal health experts are becoming increasingly vital. Veterinarians, widely regarded as trusted authorities in pet healthcare, strongly influence pet owners’ purchasing decisions. Their endorsement of CBD products for conditions such as anxiety, chronic pain, joint stiffness, and seizures can significantly enhance consumer confidence.

  Working closely with veterinary professionals also ensures that CBD formulations meet industry standards for safety, efficacy, and appropriate dosing. These collaborations help address critical concerns surrounding potential drug interactions, allowing veterinarians to confidently recommend CBD as part of integrated treatment plans. When CBD products are developed in consultation with veterinarians, the credibility of the brand is elevated, making it easier for both professionals and consumers to trust their quality. Beyond veterinary partnerships, engaging with pet care professionals—including groomers, trainers, pet nutritionists, and behaviorists—presents additional opportunities for market expansion. These professionals often maintain frequent, direct contact with pet owners and are in a unique position to educate clients about the safe and beneficial use of CBD in everyday pet wellness routines. By incorporating CBD into the holistic care practices these experts already endorse, brands can expand their reach and build stronger trust among consumers.

  Strategic alliances also open doors for cross-promotional initiatives, where CBD products are recommended alongside pet grooming, training, or behavioral support services. This approach not only boosts brand visibility but also reinforces the integration of CBD as a natural, complementary wellness solution. As awareness of natural remedies continues to rise, pet owners are increasingly drawn to expert-recommended products that support their pets' health without synthetic ingredients. In an evolving market where consumer demand for safe, natural alternatives is growing rapidly, the collaboration between CBD brands and pet care professionals will be essential for establishing CBD as a mainstream solution in pet healthcare. These partnerships offer a mutually beneficial path to education, product integrity, and long-term market growth.

Key players in Global Pet CBD Market include,

• Honest Paws LLC
• Canna-Pet LLC
• Laboratoire Francodex
• Pet Releaf
• HolistaPet
• Joy Organics
• Wet Noses Natural Dog Treat Co.
• CBD Living
• PETstock
• Garmon Corp.
• Charlotte’s Web, Inc.
• Green Roads
• HempMy Pet
• FOMO Bones

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis